Watch Palo Alto Networks, Intel, and More
The semiconductor sector might get a lift today after Palo Alto Networks (PANW) posted fiscal fourth-quarter results. PANW stock should open up by around 5%. The firm posted revenue of $2.5 billion, up by 16% Y/Y, for an adjusted earnings per share of $0.95. Palo Alto said that customers are spending to protect against modern threats. For Q1/2026, the firm is forecasting an EPS of $0.88 to $0.90.Risks remain on PANW stock. The P/E is 100.8 times, compared to the 11% effective growth rate. Watch CyberArk (CYBR) shares rising. Palo Alto is buying the firm for $25 billion.Confusion mounted for Intel (INTC) on Monday. Reports suggested that the Trump Administration take a 10% ownership in the firm. INTC closed at $23.66. The government will consider finding funds from the U.S. CHIPS and Science Act. The support is unusual, since Intel was already the biggest recipient of $10.9 billion from CHIP Act grants. However, the CEO announced plant building cancellations to cut costs.Watch for INTC to rise by around 5% this morning. Softbank (SFTBY) indicated confidence in the firm after markets closed on Monday. It will invest $2 billion, paying $23 a share.Tech stocks to consider in this space include Qualcomm (QCOM), AMD (AMD), and Broadcom (AVGO).
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


